Liver stiffness-based model predicts hepatic venous pressure gradient in patients with liver disease

HPB (Oxford). 2022 Oct;24(10):1796-1803. doi: 10.1016/j.hpb.2021.11.003. Epub 2021 Nov 12.

Abstract

Background: The aim was to develop a model to predict clinically significant portal hypertension, hepatic venous pressure gradient (HVPG) ≥10 mmHg using pre-operative noninvasive makers.

Methods: Patients who have been programmed for liver resection/transplantation were enrolled prospectively. Preoperative liver stiffness measurement (LSM), liver function test (LFT), and intraoperative HVPG were assessed. A probability score model to predict HVPG≥10 mmHg called HVPG10 score was developed and validated.

Results: A total of 161 patients [66% men, median age of 63 years] were recruited for the study. Median LSM, and HVPG were 9.5 kPa, and 5 mmHg respectively. HVPG10 score was developed using independent predictors of HVPG≥10 mmHg in the training set were LSM, total bilirubin, alkaline phosphatase, and international normalized ratio. Area under receiver operating curve of HVPG10 score in the training and validation sets were 0.91 and 0.93 respectively with a cutoff of 15. In the overall cohort, HVPG10 score≥15 had 83% accuracy, 90% sensitivity, 81% specificity and 96% negative predictive value in predicting HVPG≥10 mmHg.

Conclusion: HVPG10 score is an easy-to-use noninvasive continuous scale tool to rule out clinically significant portal hypertension in >95% patients with chronic liver disease.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alkaline Phosphatase*
  • Bilirubin
  • Female
  • Humans
  • Hypertension, Portal* / diagnosis
  • Hypertension, Portal* / etiology
  • Liver / pathology
  • Liver Cirrhosis / pathology
  • Male
  • Middle Aged
  • Portal Pressure

Substances

  • Alkaline Phosphatase
  • Bilirubin